Description

Hyaluronic acid, also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. The global hyaluronic acid market is poised to grow by US$ 3.9 billion from 2022 to 2028, registering a CAGR of 6.7% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for hyaluronic acid. The global hyaluronic acid market is segmented on the basis of application, and region. By application, the global hyaluronic acid market has been segmented into dermal fillers, ophthalmic, osteoarthritis (single injection, three injection, and five injection), vesicoureteral reflux (VUR). In terms of geography, the global hyaluronic acid market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global hyaluronic acid market is highly competitive. Some of the leading companies operating in the market are Allergan plc, Anika Therapeutics Inc., Bloomage Biotechnology Corp. Ltd., Ferring B.V., Galderma S.A., LG Chem Ltd., Lifecore Biomedical Inc., Maruha Nichiro Corporation, Sanofi S.A., Seikagaku Corporation, Shiseido Co. Ltd., Smith & Nephew plc, Zimmer Biomet Holdings Inc. Competitive landscape gives a description of the competitive nature of the global hyaluronic acid market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the hyaluronic acid market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Application: dermal fillers, ophthalmic, osteoarthritis (single injection, three injection, and five injection), vesicoureteral reflux (VUR)
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Allergan plc, Anika Therapeutics Inc., Bloomage Biotechnology Corp. Ltd., Ferring B.V., Galderma S.A., LG Chem Ltd., Lifecore Biomedical Inc., Maruha Nichiro Corporation, Sanofi S.A., Seikagaku Corporation, Shiseido Co. Ltd., Smith & Nephew plc, Zimmer Biomet Holdings Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global hyaluronic acid market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Hyaluronic acid market overview
Part 3. Market breakdown by application
– Dermal fillers
– Ophthalmic
– Osteoarthritis (single injection, three injection, and five injection)
– Vesicoureteral reflux (VUR)
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– Allergan plc
– Anika Therapeutics, Inc.
– Bloomage Biotechnology Corp., Ltd.
– Ferring B.V.
– Galderma S.A.
– LG Chem Ltd.
– Lifecore Biomedical, Inc.
– Maruha Nichiro Corporation
– Sanofi S.A.
– Seikagaku Corporation
– Shiseido Co., Ltd.
– Smith & Nephew plc
– Zimmer Biomet Holdings, Inc.
About StrategyHelix
Disclaimer